Literature DB >> 20810502

Impaired gastric emptying in primary Sjogren's syndrome.

Oskar Hammar1, Bodil Ohlsson, Per Wollmer, Thomas Mandl.   

Abstract

OBJECTIVE: To investigate the prevalence of impaired gastric emptying (IGE) and its relation to autonomic nervous dysfunction (AD), functional bowel syndrome, and inflammatory and serological variables in patients with primary Sjögren's syndrome (pSS).
METHODS: Twenty-eight patients with pSS according to the American-European Consensus Criteria were included in the study. Gastric emptying was evaluated by the octanoate breath test from which half-time (t(half)) and lag-time (t(lag)) were determined and compared with the results from 50 healthy controls. Autonomic nervous function was evaluated by 5 objective autonomic reflex tests (ART) and by the Autonomic Symptom Profile (ASP) questionnaire evaluating AD symptoms. These results were compared with previously investigated healthy ART controls and population-based ASP controls. Patients were also assessed regarding symptoms of functional bowel syndrome.
RESULTS: The t(half) and the t(lag) were significantly prolonged in patients compared to controls. Forty-three percent of patients with pSS presented signs of IGE and 29% fulfilled the criteria for gastroparesis. Significant correlations were found between t(lag) and increased levels of IgG (p = 0.02) and erythrocyte sedimentation rate (ESR; p = 0.01). In addition, rheumatoid factor (RF) seropositives showed objective signs of IGE to a greater extent than RF seronegatives. No associations between IGE, ART variables, ASP variables, or gastrointestinal symptoms were found.
CONCLUSION: IGE was common in pSS. Associations with inflammatory and serological features of pSS could imply immunological mechanisms behind the IGE. Objective signs of IGE were not associated with objective signs or subjective symptoms of AD or functional bowel syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20810502     DOI: 10.3899/jrheum.100280

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.

Authors:  W-F Ng; A J Stangroom; A Davidson; K Wilton; S Mitchell; J L Newton
Journal:  QJM       Date:  2012-09-13

2.  Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).

Authors:  Mariette Bengtsson; Oskar Hammar; Thomas Mandl; Bodil Ohlsson
Journal:  BMC Gastroenterol       Date:  2011-11-10       Impact factor: 3.067

3.  Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.

Authors:  Kristofer Andréasson; Bodil Ohlsson; Thomas Mandl
Journal:  Arthritis Res Ther       Date:  2016-01-12       Impact factor: 5.156

4.  Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.

Authors:  Thomas Mandl; Jan Marsal; Peter Olsson; Bodil Ohlsson; Kristofer Andréasson
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

5.  The Frequency of Primary Sjogren's Syndrome and Fibromyalgia in Irritable Bowel Syndrome.

Authors:  Funda Erbasan; Yesim Cekin; Deniz Turgut Coban; Ugur Karasu; Dinc Suren; Ayhan H Cekin
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

6.  The impact of risk factors on gastroparesis at an urban medical center.

Authors:  Katherine Duffey; Michelle Hannon; Joseph Yoo; Nicholas Perkons; Charles Intenzo; Stephanie Moleski; Anthony J DiMarino
Journal:  Ann Gastroenterol       Date:  2020-04-02

Review 7.  Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome.

Authors:  Kristen Davies; Wan-Fai Ng
Journal:  Front Immunol       Date:  2021-07-26       Impact factor: 7.561

8.  Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.

Authors:  Julia L Newton; James Frith; Danielle Powell; Kate Hackett; Katharine Wilton; Simon Bowman; Elizabeth Price; Colin Pease; Jacqueline Andrews; Paul Emery; John Hunter; Monica Gupta; Saravanan Vadivelu; Ian Giles; David Isenberg; Peter Lanyon; Adrian Jones; Marian Regan; Annie Cooper; Robert Moots; Nurhan Sutcliffe; Michele Bombardieri; Costantino Pitzalis; John McLaren; Steven Young-Min; Bhaskar Dasgupta; Bridget Griffiths; Dennis Lendrem; Sheryl Mitchell; Wan-Fai Ng
Journal:  Ann Rheum Dis       Date:  2012-05-05       Impact factor: 19.103

9.  Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren's syndrome and rheumatoid arthritis.

Authors:  Kristofer Andréasson; Tore Saxne; Agneta Scheja; Izabela Bartosik; Thomas Mandl; Roger Hesselstrand
Journal:  Arthritis Res Ther       Date:  2014-02-06       Impact factor: 5.156

Review 10.  Neuroimmunogastroenterology: At the Interface of Neuroimmunology and Gastroenterology.

Authors:  John Michael S Sanchez; J Scott McNally; Melissa M Cortez; James Hemp; Laura A Pace; Stacey L Clardy
Journal:  Front Neurol       Date:  2020-07-31       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.